Skip to main content
Log in

Continuous subcutaneous insulin infusion not cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. subcutaneous insulin: pumps or injections?

  2. National Health Service

Reference

  • Blair JC, et al. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. BMJ 2019: l1226, No. 365, 3 Apr 2019. Available from: URL: https://doi.org/10.1136/bmj.l1226

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Continuous subcutaneous insulin infusion not cost effective. PharmacoEcon Outcomes News 826, 6 (2019). https://doi.org/10.1007/s40274-019-5808-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5808-7

Navigation